Will justice be done? From Business Wire: Chuck and Gena Norris announced today that they have filed a lawsuit against eleven drug companies, including McKesson and Bracco, that they claim are responsible for the gadolinium contrast dye used during the MRIs that nearly cost Gena her life. The lawsuit alleges that Gena was poisoned by […]
The FDA’s Pharmacy Compounding Advisory Committee (PCAC) is holding another meeting, this time to decide the fate of resveratrol and pregnenolone, among other compounded medicines. Action Alert! For some time now, we’ve been monitoring the FDA’s PCAC as it recommends which substances should be allowed to be compounded. Almost always, PCAC follows the lead of […]
Will doctors and hospitals finally be required to disclose prices? Action Alert! although an overhaul of Obamacare seems off the table for the time being, a bill has been introduced in the House that includes a much-needed reform. As we’ve noted previously, there are countless horror stories about patients getting stuck with astronomical hospital bills, […]
Many in Congress do, according to a letter nearly 80 representatives just sent to the FDA, USDA, and EPA. Action Alert! The letter, presumably inspired by big corporate donors, calls for the agencies to provide a “consistent, appropriate” approach to the regulation of biotechnology. On the one hand, the FDA has proposed to regulate any […]
Another potential blockbuster drug has flopped. Despite this, the feds still have natural alternative treatments in the crosshairs. From Forbes: Investors poured hundreds of millions of dollars into Axovant and its experimental Alzheimer’s drug, intepirdine. But in the end, the medicine was no different from 99% of medicines tested against the brain-wasting disease since 2002 — it […]
Consumers are targeted by the FDA’s newest GMO propaganda campaign. From the FDA: The U.S Food and Drug Administration is announcing public meetings to be held in Charlotte, North Carolina, and San Francisco, California, regarding its Agricultural Biotechnology Education and Outreach Initiative. Congress appropriated $3 million to fund this initiative, which calls upon the FDA to […]
Legislation, approved in the Senate, must now pass the House of Representatives. Action Alert! Earlier this year, the “Right to Try” legislation introduced by Sen. Ron Johnson (R-WI) passed by unanimous consent in the Senate. It had a hearing last week in the House, and awaits approval. As things stand now, FDA bureaucrats continue to […]
A new bill has important provisions that will help stop fake organics from flooding US markets. Action Alert! A bill has been introduced by Rep. John Faso (R-NY) to address some of the program’s shortcomings in ensuring the integrity of imported organics. This follows an Office of the Inspector General (OIG) audit report that found […]
No, not by Congress—by a Trump executive order signed today. President Trump has signed an executive order expanding access to “association health plans”—policies that do not have to adhere to a number of Obamacare rules. The idea, strongly supported by Sen. Rand Paul, is that individuals with a common profession or interest could band together and be […]
Thirty-seven state attorneys general recently wrote to American’s Health Insurance Plans (AHIP), saying that the status quo is unacceptable. We agree. Action Alert! The letter urges AHIP to encourage healthcare providers to prioritize non-opioid pain management options–such as physical therapy, acupuncture, chiropractic care, and massage—over opioid prescriptions in the treatment of chronic pain. Opioid addiction […]